FDA Drug recall D-0513-2017
Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist
- FDA Drug
- Class II
- completed
- Published 2017-03-15
On 2017-03-15 the FDA classified a Class II recall of Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist by Mckesson Packaging Services, citing presence of Foreign Substance: foreign material found in the bulk inventory.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0513-2017 |
| Classification | Class II |
| Status | completed |
| Initiated | 2017-02-23 |
| Published | 2017-03-15 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mckesson Packaging Services |
| Distribution | US |
Product
Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.
Reason
Presence of Foreign Substance: foreign material found in the bulk inventory.
Identifiers
| code_info | Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0513-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.